72 results
Page 2 of 4
424B5
dzd sf1wq5g3wr0
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
2rlmu
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
8v8jxoa27jgv
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
9hrsuj4 hioa
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
4oss3p95n3mnw556urb
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-10.1
3ihb l5oh8
26 Jun 20
Departure of Directors or Certain Officers
4:06pm
425
hz5hpw
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
rlj486b3sujw0f00ftb
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
eo8ofmdxyovjsd5wrkyk
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
k68 b8j1qv16k
24 Jun 20
Business combination disclosure
4:03pm
425
m5vaefwt4r8f
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.2
4e89a1dt7yrx7yx8
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
35w2giweea
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm